News
12-12-2013, 02:42 AM
A remarkable 98.7 percent of certain lower-risk breast cancer patients were cancer free for at least three years after taking a combination of the drugs Herceptin and Taxol, a study has found.
More... (http://www.news-medical.net/news/20131212/Study-Taxol-and-Herceptin-highly-effective-for-lower-risk-breast-cancer-patients.aspx)
More... (http://www.news-medical.net/news/20131212/Study-Taxol-and-Herceptin-highly-effective-for-lower-risk-breast-cancer-patients.aspx)